CA2894868C - Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif - Google Patents

Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif Download PDF

Info

Publication number
CA2894868C
CA2894868C CA2894868A CA2894868A CA2894868C CA 2894868 C CA2894868 C CA 2894868C CA 2894868 A CA2894868 A CA 2894868A CA 2894868 A CA2894868 A CA 2894868A CA 2894868 C CA2894868 C CA 2894868C
Authority
CA
Canada
Prior art keywords
pif
seq
antibodies
antibody
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2894868A
Other languages
English (en)
Other versions
CA2894868A1 (fr
Inventor
Eytan R. Barnea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioIncept LLC
Original Assignee
BioIncept LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioIncept LLC filed Critical BioIncept LLC
Priority to CA2985469A priority Critical patent/CA2985469A1/fr
Priority claimed from CA2584690A external-priority patent/CA2584690C/fr
Publication of CA2894868A1 publication Critical patent/CA2894868A1/fr
Application granted granted Critical
Publication of CA2894868C publication Critical patent/CA2894868C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Une composition destinée à détecter la présence dun peptide de facteur de préimplantation (PIF) dans un fluide, la composition comprenant des anticorps PIF et ledit fluide.
CA2894868A 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif Expired - Fee Related CA2894868C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2985469A CA2985469A1 (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51337003P 2003-10-22 2003-10-22
US60/513,370 2003-10-22
US48224403A 2003-12-22 2003-12-22
US10/482,244 2003-12-22
CA2584690A CA2584690C (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2584690A Division CA2584690C (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2985469A Division CA2985469A1 (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Publications (2)

Publication Number Publication Date
CA2894868A1 CA2894868A1 (fr) 2005-05-06
CA2894868C true CA2894868C (fr) 2017-12-12

Family

ID=45349626

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2985469A Abandoned CA2985469A1 (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif
CA2894868A Expired - Fee Related CA2894868C (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2985469A Abandoned CA2985469A1 (fr) 2003-10-22 2004-10-22 Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif

Country Status (2)

Country Link
CA (2) CA2985469A1 (fr)
NZ (1) NZ578577A (fr)

Also Published As

Publication number Publication date
CA2894868A1 (fr) 2005-05-06
CA2985469A1 (fr) 2005-05-06
NZ578577A (en) 2011-12-22

Similar Documents

Publication Publication Date Title
US7723289B2 (en) PIF tetrapeptides
IL175063A (en) Use of pif peptides in the manufacture of a medicament for treating intolerance to embryo implantation
CA3167498A1 (fr) Groupes d'epitopes de lymphocytes t et compositions associees utiles dans la prevention, le diagnostic et le traitement de la covid-19
US20190054139A1 (en) Compositions and methods for modulating the immune system
KR102158225B1 (ko) 헬퍼 t세포의 활성화 방법
US8222211B2 (en) Methods of administering PIF agonist peptides and uses thereof
AU2019203459A1 (en) PIF binding as a marker for immune dysregulation
JP2005512953A (ja) 着床前因子の新しいアッセイ方法および着床前因子ペプチド
CA2894868C (fr) Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif
US20230013244A1 (en) Pif binding as a marker for immune dysregulation
EP1680442B1 (fr) Activites biologiques de peptides pif
Kling et al. Experience with Allogeneic Leukocyte Immunization (Ai) for Implantation Failure in the In‐Vitro Fertilization Program
Kamada et al. Specific cytotoxicity of antibody to YAL-198, a sperm antigen peptide, to murine zygote
Blois et al. Therapy with Dendritic Cells (DCs) control fetal abortion rate in the CBA/J× DBA/2J mouse model
Zenclussen et al. Increased expression of chemokine receptor 5 (CCR5) in blood and decidual cells in a mouse model for preeclampsia (PE)
Lidström et al. Suppressor macrophages in early pregnancy human decidua
Fernekorn et al. Regulation of leukocyte recruitment to the murine maternal/fetal interface by specialized patterns of vascular adhesion receptors
Uthoff et al. The impact of maternal allergic sensitization on the development of pre‐and postnatal immunity
Fitzgerald et al. Is Stat3 activation in trophoblast cells required for invasiveness?
Hammadeh et al. Relationship between cytokine concentration in serum, pre‐ovulatory follicular fluid and icsi outcome
Koc et al. Enhancement of immunogenicity of JEG‐3 Cells by ectopic expression of HLA‐A* 0201 and CD80
Jerzak et al. Extracellular matrix proteins dependent apoptosis of T Cells in women with a history of recurrent spontaneous abortion
Abram et al. Systemic cytokine response during listeria monocytogenes infection in pregnant BALB/C Mice
Jonáková et al. Mutual interactions of boar seminal plasma proteins studied by immunological and chromatographic methods
Jonsson et al. Cytokine profile in women with preeclampsia

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150618

MKLA Lapsed

Effective date: 20221024